Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

ABBOTT LABORATORIES Registration Form 2008

Aug 26, 2008

29777_rf_2008-08-26_0446bbda-68ae-42d3-971b-34c0f7ce030b.zip

Registration Form

Open in viewer

Opens in your device viewer

{# SEO P0-1: filing HTML is rendered server-side so Googlebot sees the full text without executing JS or following an iframe to a Disallow'd CDN path. The content has already been sanitized through filings.seo.sanitize_filing_html. #}

S-8 1 a08-17292_2s8.htm S-8

*As filed with the Securities and Exchange Commission on August 26, 2008.*

*Registration No. 333-*

*UNITED STATES*

*SECURITIES AND EXCHANGE COMMISSION*

*Washington, D.C. 20549*

*FORM S-8*

*REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933*

*Abbott Laboratories*

(Exact name of registrant as specified in its charter)

Illinois 36-0698440
(State or other jurisdiction of (I.R.S. Employer
incorporation or organization) Identification No.)
Abbott Laboratories
100 Abbott Park Road
Abbott Park, Illinois 60064-6400
(Address of Principal Executive Offices) (Zip Code)

*ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM*

(Full title of the plan)

*Laura J. Schumacher*

*Abbott Laboratories*

*100 Abbott Park Road*

*Abbott Park, Illinois 60064-6400*

(Name and address of agent for service)

Telephone number, including area code, of agent for service: (847) 937-6100

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

| Large
accelerated filer | x | Accelerated
filer | o |
| --- | --- | --- | --- |
| Non-accelerated
filer | o | Smaller
reporting company | o |
| (Do not check if a smaller reporting
company) | | | |

*CALCULATION OF REGISTRATION FEE*

Title of securities to be registered Amount to be registered Proposed maximum offering price per share (a) Proposed maximum aggregate offering price (a) Amount of registration fee (a)
Common shares (without par value) 5,000,000 $ 57.83 $ 289,150,000 $ 11,364

(a) In addition, pursuant to Rule 416(c) under the Securities Act of 1933, this registration statement also covers an indeterminate amount of interests to be offered or sold pursuant to the employee benefit plan described herein. The filing fee has been calculated in accordance with Rule 457(c) based on the average of the high and low prices of Registrant’s Common Shares reported on the New York Stock Exchange on August 21, 2008.

SEQ.=1,FOLIO='',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'

Pursuant to General Instruction E, the contents of Abbott Laboratories Stock Retirement Program Registration Statement on Form S-8 (File no. 33-50452) are incorporated herein by reference.

Part II. Information Required in the Registration Statement

Item 8. Exhibits

Reference is made to the Exhibit Index which is incorporated herein by reference. Neither an opinion of counsel concerning the Program’s compliance with the requirements of ERISA nor an Internal Revenue Service (“IRS”) determination letter is furnished because the Registrant undertakes that it will submit, or has submitted, the Abbott Laboratories Stock Retirement Program and any amendments thereto to the IRS in a timely manner and has made or will make all changes required by the IRS in order to qualify the Program.

2

SEQ.=1,FOLIO='2',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'

SIGNATURES

THE REGISTRANT. Pursuant to the requirements of the Securities Act of 1933, the registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on August 25, 2008.

ABBOTT LABORATORIES
By: /s/ Miles D. White
Miles D. White,
Chairman of the Board and
Chief Executive Officer

3

SEQ.=1,FOLIO='3',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'

Each person whose signature appears below constitutes and appoints Miles D. White and Laura Schumacher, Esq., and each of them, as his or her true and lawful attorney-in-fact and agent, with full power of substitution and resubstitution, for him or her and in his or her name, place and stead, in any and all capacities, to sign any and all amendments to this registration statement, and to file the same with all exhibits thereto, and other documents in connection therewith, with the Commission, granting unto said attorney-in-fact and agent full power and authority to do and perform each act and thing requisite and necessary to be done, as fully to all intents and purposes as he or she might or could do in person, hereby ratifying and confirming all that said attorney-in-fact and agent, or his or her substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities and on the dates indicated.

Signature Title Date
/s/
Miles D. White Chairman
of the Board, August
25, 2008
Miles
D. White Chief
Executive Officer, and
Director
/s/
Thomas C. Freyman Executive
Vice President, Finance and August
25, 2008
Thomas
C. Freyman Chief
Financial Officer (Principal
Financial
Officer)
/s/
Greg W. Linder Vice
President and Controller August
25, 2008
Greg
W. Linder (Principal
Accounting Officer)
/s/
Roxanne S. Austin Director August
25, 2008
Roxanne
S. Austin
/s/
William M. Daley Director August
25, 2008
William
M. Daley
/s/
W. James Farrell Director August
25, 2008
W.
James Farrell
/s/
H. Laurance Fuller Director August
25, 2008
H.
Laurance Fuller
/s/ William A. Osborn Director August 25, 2008
William A. Osborn

4

SEQ.=1,FOLIO='4',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'

/s/ David A. L. Owen Director August 25, 2008
David
A. L. Owen
/s/
Boone Powell Jr. Director August
25, 2008
Boone
Powell Jr.
/s/
W. Ann Reynolds Director August
25, 2008
W.
Ann Reynolds
/s/
Roy S. Roberts Director August
25, 2008
Roy
S. Roberts
/s/ Samuel C. Scott III Director August 25, 2008
Samuel
C. Scott III
/s/
William D. Smithburg Director August
25, 2008
William
D. Smithburg
/s/ Glenn F. Tilton Director August 25, 2008
Glenn
F. Tilton

5

SEQ.=1,FOLIO='5',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'

THE PLAN. Pursuant to the requirements of the Securities Act of 1933, the Abbott Laboratories Stock Retirement Program has duly caused this registration statement to be signed on its behalf by the undersigned, thereunto duly authorized, in unincorporated Lake County, and State of Illinois, on the 25 th day of August, 2008.

ABBOTT LABORATORIES STOCK RETIREMENT PROGRAM
By: /s/ Stephen R. Fussell
Stephen R. Fussell, Plan Administrator

6

SEQ.=1,FOLIO='6',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'

EXHIBIT INDEX

Exhibit No. Description
23.1 Consent of Deloitte & Touche LLP.
23.2 Consent of Deloitte & Touche LLP.
23.3 Consent of Grant Thornton LLP.
24 Power of Attorney is included on the signature page.

7

SEQ.=1,FOLIO='7',FILE='C:\JMS\mblount\08-17292-2\task3111099\17292-2-ba.htm',USER='mblount',CD='Aug 26 14:38 2008'